Production of (177)Lu for Targeted Radionuclide Therapy: Available Options.

@article{Dash2015ProductionO,
  title={Production of (177)Lu for Targeted Radionuclide Therapy: Available Options.},
  author={Ashutosh Dash and Maroor Raghavan Ambikalmajan Pillai and Furn F Russ Knapp},
  journal={Nuclear medicine and molecular imaging},
  year={2015},
  volume={49 2},
  pages={85-107}
}
BACKGROUND This review provides a comprehensive summary of the production of (177)Lu to meet expected future research and clinical demands. Availability of options represents the cornerstone for sustainable growth for the routine production of adequate activity levels of (177)Lu having the required quality for preparation of a variety of (177)Lu-labeled radiopharmaceuticals. The tremendous prospects associated with production of (177)Lu for use in targeted radionuclide therapy (TRT) dictate… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 89 references

Production and radiochemical separation of 147Gd

  • FO Denzler, NA Lebedev, AF Novgorodov, F Roesch, SM. Qaim
  • Appl Radiat Isot
  • 1997
Highly Influential
10 Excerpts

Aspects of yield and specific activity of (n, γ) produced 177Lu used in targeted radionuclide therapy

  • KV Vimalnath, P Shetty, SP Lohar, SVC Adya, SK Thulasidas, S Chakraborty
  • J Radioanal Nucl Chem
  • 2014
Highly Influential
7 Excerpts

On the practical aspects of large-scale production of 177Lu for peptide receptor radionuclide therapy using direct neutron activation of 176Lu in a medium flux research reactor: The Indian experience

  • S Chakraborty, KV Vimalnath, SP Lohar, P Shetty, A. Dash
  • J Radioanal Nucl Chem
  • 2014
Highly Influential
8 Excerpts

A process for the separation of 177Lu from neutron irradiated 176Yb targets

  • EP Horwitz, DR Mc Alister, AH Bond, RE Barrans, JM. Williamson
  • Appl Radiat Isot
  • 2005
Highly Influential
4 Excerpts

Electrochemical separation: promises, opportunities, and challenges to develop next-generation radionuclide generators to meet clinical demands

  • A Dash, R. Chakravarty
  • Ind Eng Chem Res
  • 2014
1 Excerpt

Radiolanthanide-labeled HA particles in the treatment of rheumatoid arthritis: ready-to-use cold kits for rapid formulation in hospital radiopharmacy

  • S Chakraborty, KV Vimalnath, A Rajeswari, HD Sarma, A Shinto, ER Radhakrishnan
  • J Radioanal Nucl Chem
  • 2014

Activation cross-sections of longer lived products of deuteron induced nuclear reactions on ytterbium up to 40 MeV

  • F Tárkányi, F Ditrói, S Takács, A Hermanne, H Yamazaki, M Baba
  • Nucl Instr Meth B. 2013;304:36–48
  • 2013
1 Excerpt

Similar Papers

Loading similar papers…